Galvus Met is a high-performance oral anti-diabetic medication designed for adults with Type 2 Diabetes whose blood sugar levels are not adequately controlled by Metformin alone. This combination therapy simplifies your treatment regimen while providing superior glucose management.

- Dual-Mechanism Synergy: 1. Vildagliptin (DPP-4 Inhibitor): Stimulates the pancreas to produce more insulin when blood sugar is high and reduces the production of glucagon (a hormone that raises blood sugar).

2. Metformin (Biguanide): Helps your body respond better to its own insulin and reduces the amount of sugar produced by the liver.

- Effective Post-Meal Control: Specifically targets mealtime glucose spikes, helping you maintain a more stable HbA1c profile throughout the day.

- Low Hypoglycemia Risk: Unlike some other diabetes medications, Galvus Met has a lower risk of causing dangerously low blood sugar (hypoglycemia) when used as directed.

- Weight Neutrality: Generally does not cause weight gain, which is a significant advantage for long-term diabetes management.

Key Features:

- Convenient Combination: Two powerful active ingredients in a single tablet to improve patient adherence.

- 50/500mg Strength: A standard starting or maintenance dose for balanced glycemic control.

- 10-Tablet Strip: Compact packaging suitable for short-term refills or travel convenience.

How to Use:

- Dosage: Take exactly as prescribed by your doctor. Usually taken twice daily (one in the morning and one in the evening).

- Administration: Must be taken with or just after food to minimize potential stomach upset caused by Metformin.

- Compliance: Do not skip doses; consistent timing is essential for maintaining optimal blood sugar levels.